Table 2. Demographics of AIDS-related and non-AIDS-related death and predictors between 2006 and 2013.
| AIDS-related deatha | Non-AIDS-related deathb | |||||
|---|---|---|---|---|---|---|
| Mortality rate | HR (95% CI) | Adjusted HR (95% CI) | Mortality rate | HR (95% CI) | Adjusted HR (95% CI) | |
| Gender | ||||||
| Female | 3.72 (150/4036.6) | 1 | 1 | 1.69 (165/9766.9) | 1 | 1 |
| Male | 5.31 (591/11129.6 | 1.295 (1.082–1.551) | 0.973 (0.772–1.226) | 2.23 (589/26389.7) | 1.262 (1.003–1,586) | 1.868 (1.264–2.761) |
| Age at the end of follow-up | ||||||
| <40 | 3.82 (307/8029.8) | 1 | 1 | 1.62 (356/21993.3) | 1 | 1 |
| 40~59 | 5.12 (299/5834.5) | 1.299 (1.108–1.524) | 1.269 (1.029–1.565) | 2.12 (252/11903.5) | 1.907 (1.532–2.374) | 1.908 (1.343–2.711) |
| ≥60 | 10.37 (135/1301.9) | 2.327 (1.900–2.851) | 1.798 (1.368–2.362) | 6.46 (146/2259.7) | 6.972 (5.524–8.800) | 5.755 (3.814–8.683) |
| Area of registry | ||||||
| Zhejiang | 5.21 (462/8864.5) | 1 | 1 | 1.90 (351/18456.2) | 1 | 1 |
| Other provinces | 4.43 (279/6301.7) | 0.878 (0.757–1.109) | 0.706 (0.517–0.965) | 2.28 (403/17700.4) | 0.761 (0.630–0.918) | 0.640 (0.399–1.027) |
| Area of residence | ||||||
| Zhejiang | 4.42 (512/11574.0) | 1 | 1 | 1.67 (427/25583.2) | 1 | 1 |
| Other province | 6.37 (229/3592.2) | 1.530 (1.309–1.789) | 1.536 (1.108–2.129) | 3.09 (327/10573.3) | 1.453 (1.193–1.769) | 1.763 (1.084–2.866) |
| Education | ||||||
| Primary school or less | 5.68 (620/10917.8) | 1 | 1 | 2.52 (646/25675.4) | 1 | 1 |
| Junior high school | 3.31 (83/2507.5) | 0.581 (0.462–0.731) | 0.740 (0.550–0.996) | 1.27 (78/6117.7) | 0.611 (0.464–0.804) | 1.079 (0.719–1.619) |
| Senior high school or more | 2.03 (35/1727.2) | 0.344 (0.245–0.483) | 1.030 (0.683–1.554) | 0.70 (30/4281.4) | 0.187 (0.110–0.319) | 0.369 (0.147–0.926) |
| Transmission routes | ||||||
| MSM | 2.39 (91/3801.8) | 1 | 1 | 0.80 (74/9200.4) | 1 | 1 |
| Heterosexual | 5.65 (563/9962.4) | 2.513 (2.014–3.137) | 1.377 (1.066–1.777) | 2.18 (480/21977.0) | 4.673 (3.328–6.561) | 2.134 (1.340–3.399) |
| IDU | 4.44 (37/834.1) | 2.351 (1.603–3.448) | 1.017 (0.626–1.651) | 3.87 (139/3592.7) | 4.262 (2.605–6.973) | 1.716 (0.831–3.544) |
| Other/unknown | 8.81 (50/567.8) | 4.444 (3.145–6.279) | 1.180 (0.746–1.865) | 4.40 (61/1386.4) | 12.470 (7.841–19.830) | 1.756 (0.756–4.080) |
| Late diagnosis | ||||||
| No | 2.16 (146/6771.1) | 1 | 1 | 2.16 (586/27083.5) | 1 | 1 |
| Yes | 7.09 (595/8395.1) | 2.364 (1.963–2.846) | 4.260 (3.344–5.426) | 1.85 (168/9073.1) | 0.981 (0.721–1.101) | 2.277 (1.618–3.205) |
| HAART | ||||||
| No | 40.51 (496/1224.3) | 1 | 1 | 2.94 (643/12681.1) | 1 | 1 |
| Yes | 1.76 (245/13941.9) | 0.055 (0.047–0.064) | 0.176 (0.144–0.217) | 1.22 (111/23475.4) | 0.112 (0.087–0.144) | 0.141 (0.102–0.196) |
| TB coinfection | ||||||
| No | 2.79 (376/13485.0) | 1 | 1 | 1.07 (335/31449.2) | 1 | 1 |
| Yes | 6.19 (81/1309.5) | 2.234 (1.757–2.841) | 1.554 (1.180–2.047) | 0.90 (17/1896.4) | 0.127 (0.656–1.934) | 0.828 (0.455–1.505) |
| Unknown | 76.4 (284/371.7) | 18.165 (15.485–21.309) | 2.833 (2.247–3.572) | 14.30 (402/2811.0) | 14.338 (11.821–17.390) | 2.403 (1.622–3.562) |
| Last CD4+ T-cell count (cells/mm3) | ||||||
| 0–99 | 26.24 (343/1306.9) | 1 | 1 | 4.41 (58/1313.9) | 1 | 1 |
| 100–199 | 3.13 (89/2841.2) | 0.125 (0.099–0.159) | 0.160 (0.125–0.204) | 1.26 (36/2862.3) | 0.294 (0.194–0.446) | 0.353 (0.230–0.543) |
| 200–499 | 0.84 (73/8734.7) | 0.036 (0.028–0.047) | 0.059 (0.045–0.079) | 0.57 (104/18327.7) | 0.135 (0.098–0.186) | 0.234 (0.164–0.334) |
| ≥500 | 0.46 (10/2170.8) | 0.019 (0.010–0.037) | 0.034 (0.017–0.068) | 0.26 (20/7821.5) | 0.061 (0.037–0.102) | 0.102 (0.059–0.175) |
aAmong AIDS patients.
bAmong HIV/AIDS patients.
HR: hazard ratio; CI: confidence interval; MSM: men who have sex with men; IDU: Injected drug use; HAART: highly active antiretroviral treatment; TB: tuberculosis.